M. Warmuth-Metz

981 total citations
24 papers, 398 citations indexed

About

M. Warmuth-Metz is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Neurology. According to data from OpenAlex, M. Warmuth-Metz has authored 24 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 9 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Neurology. Recurrent topics in M. Warmuth-Metz's work include Glioma Diagnosis and Treatment (13 papers), Pituitary Gland Disorders and Treatments (9 papers) and Neuroblastoma Research and Treatments (5 papers). M. Warmuth-Metz is often cited by papers focused on Glioma Diagnosis and Treatment (13 papers), Pituitary Gland Disorders and Treatments (9 papers) and Neuroblastoma Research and Treatments (5 papers). M. Warmuth-Metz collaborates with scholars based in Germany, Switzerland and Austria. M. Warmuth-Metz's co-authors include Hermann L. Müller, U Gebhardt, Gudrun Fleischhack, Rolf‐Dieter Kortmann, N. Sörensen, R Kolb, André O. von Bueren, Gabriele Calaminus, Stefan Rutkowski and Torsten Pietsch and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Endocrinology and Neuro-Oncology.

In The Last Decade

M. Warmuth-Metz

23 papers receiving 391 citations

Peers

M. Warmuth-Metz
Darryl C. Longee United States
Ge Jia China
B Önol Türkiye
Stephen Laughton New Zealand
María E. Echevarría United States
P. Berlier France
G Szeifert Hungary
Darryl C. Longee United States
M. Warmuth-Metz
Citations per year, relative to M. Warmuth-Metz M. Warmuth-Metz (= 1×) peers Darryl C. Longee

Countries citing papers authored by M. Warmuth-Metz

Since Specialization
Citations

This map shows the geographic impact of M. Warmuth-Metz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Warmuth-Metz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Warmuth-Metz more than expected).

Fields of papers citing papers by M. Warmuth-Metz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Warmuth-Metz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Warmuth-Metz. The network helps show where M. Warmuth-Metz may publish in the future.

Co-authorship network of co-authors of M. Warmuth-Metz

This figure shows the co-authorship network connecting the top 25 collaborators of M. Warmuth-Metz. A scholar is included among the top collaborators of M. Warmuth-Metz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Warmuth-Metz. M. Warmuth-Metz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Daubenbüchel, Anna M., et al.. (2015). Hydrocephalus and hypothalamic involvement in pediatric patients with craniopharyngioma or cysts of Rathke's pouch: impact on long-term prognosis. European Journal of Endocrinology. 172(5). 561–569. 30 indexed citations
2.
Hoffmann, Anika, M. Warmuth-Metz, U Gebhardt, & Hermann L. Müller. (2015). Childhood craniopharyngioma – Changes of treatment strategies in the trials KRANIOPHARYNGEOM 2000/2007. Experimental and Clinical Endocrinology & Diabetes. 122(3). 3 indexed citations
4.
Müller, Klaus, Annika Schlamann, Matthias Gückenberger, et al.. (2014). Craniospinal irradiation with concurrent temozolomide for primary metastatic pediatric high-grade or diffuse intrinsic pontine gliomas. Strahlentherapie und Onkologie. 190(4). 377–381. 18 indexed citations
5.
Müller, Klaus, Annika Schlamann, Clemens Seidel, et al.. (2013). Craniospinal irradiation with concurrent temozolomide and nimotuzumab in a child with primary metastatic diffuse intrinsic pontine glioma. Strahlentherapie und Onkologie. 189(8). 693–696. 6 indexed citations
6.
Müller, Hermann L., et al.. (2012). Meningioma as second malignant neoplasm after oncological treatment during childhood. Strahlentherapie und Onkologie. 188(5). 438–441. 13 indexed citations
7.
Bueren, André O. von, Katja von Hoff, Torsten Pietsch, et al.. (2011). Treatment of young children with localized medulloblastoma by chemotherapy alone: Results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology. Neuro-Oncology. 13(6). 669–679. 125 indexed citations
10.
Bode, U., Maura Massimino, M. Warmuth-Metz, et al.. (2008). Phase III trial of nimotuzumab for the treatment of newly diagnosed diffuse intrinsic pontine gliomas in children and adolescents. Journal of Clinical Oncology. 26(15_suppl). 2058–2058. 13 indexed citations
11.
Grotzer, Michael A., Katja von Hoff, André O. von Bueren, et al.. (2007). Which Clinical and Biological Tumor Markers Proved Predictive in the Prospective Multicenter Trial HIT’91 - Implications for Investigating Childhood Medulloblastoma. Klinische Pädiatrie. 219(6). 312–317. 9 indexed citations
12.
Bode, U., et al.. (2007). Final report of a phase II trial of nimotuzumab in the treatment of refractory and relapsed high-grade gliomas in children and adolescents. Journal of Clinical Oncology. 25(18_suppl). 2006–2006. 25 indexed citations
13.
Müller, Hermann L., U Gebhardt, Fabian Pöhl, et al.. (2006). Relapse Pattern After Complete Resection and Early Progression After Incomplete Resection of Childhood Craniopharyngioma. Klinische Pädiatrie. 218(6). 315–320. 36 indexed citations
14.
Klotz, Peter, Dennis Tappe, Marianne Abele‐Horn, et al.. (2006). Cerebral mass in a 13-year-old girl following long-term sojourn in the Tropics. Journal of Medical Microbiology. 55(3). 345–347. 9 indexed citations
15.
Bode, U., et al.. (2006). Results of a phase II trial of h-R3 monoclonal antibody (nimotuzumab) in the treatment of resistant or relapsed high-grade gliomas in children and adolescents. Journal of Clinical Oncology. 24(18_suppl). 1522–1522. 12 indexed citations
17.
Müller, Hermann L., U Gebhardt, N Etavard-Gorris, et al.. (2004). Prognosis and Sequela in Patients with Childhood Craniopharyngioma - Results of HIT-ENDO and Update on KRANIOPHARYNGEOM 2000. Klinische Pädiatrie. 216(6). 343–348. 58 indexed citations
18.
Lindner, A., et al.. (1997). Iatrogenic spinal epidural abscesses: early diagnosis essential for good outcome.. PubMed. 2(5). 201–5. 22 indexed citations
19.
Schmitt, R., et al.. (1990). [Computed tomography of soft tissue tumors of the hand and the forearm].. PubMed. 30(4). 185–92. 2 indexed citations
20.
Schmitt, R., et al.. (1989). [Computerized tomography of the hand: examination technic, normal anatomy, indications].. PubMed. 21(2). 89–96. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026